Insider · CIK 0001859718
Areta Kupchyk
Files at ANEB (Anebulo Pharmaceuticals, Inc.). First filing -, latest -.
In brief
Areta Kupchyk files SEC Form 4 as director at ANEB (Anebulo Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Areta Kupchyk has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 4, 2025 | ANEB Anebulo Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Apr 7, 2025 |
| Apr 4, 2025 | ANEB Anebulo Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +2,647 | $0.00 | $0 | 2,647 | Apr 7, 2025 |
Questions about Areta Kupchyk
Answered from the filings on this page, as of the latest one.
Is Areta Kupchyk buying or selling?
Areta Kupchyk has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Areta Kupchyk's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Areta Kupchyk has 0.
Where does Areta Kupchyk file Form 4?
Areta Kupchyk has filed Form 4 at ANEB (Anebulo Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.